About Sompharmaceuticals
Sompharmaceuticals is a company based in Epalinges (Switzerland) founded in 2012 was acquired by Amryt Pharma in April 2016.. Sompharmaceuticals has raised $851.87 thousand across 2 funding rounds from investors including Amryt Pharma. Sompharmaceuticals operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others.
- Headquarter Epalinges, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$851.87 K (USD)
in 2 rounds
-
Latest Funding Round
$851.87 K (USD), Series A
Apr 29, 2014
- Investors
-
Employee Count
Employee Count
-
Acquired by
Amryt Pharma
(Apr 18, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sompharmaceuticals
Sompharmaceuticals has successfully raised a total of $851.87K across 2 strategic funding rounds. The most recent funding activity was a Series A round of $851.87 thousand completed in April 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $851,866
-
First Round
First Round
(15 Oct 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2014 | Amount | Series A - Sompharmaceuticals | Valuation |
investors |
|
| Oct, 2013 | Amount | Grant - Sompharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sompharmaceuticals
Sompharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Amryt Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for rare dermatological and orphan diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sompharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sompharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sompharmaceuticals Comparisons
Competitors of Sompharmaceuticals
Sompharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for rare and orphan diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat rare genetic diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sompharmaceuticals
When was Sompharmaceuticals founded?
Sompharmaceuticals was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Sompharmaceuticals located?
Sompharmaceuticals is headquartered in Epalinges, Switzerland. It is registered at Epalinges, Vaud, Switzerland.
Is Sompharmaceuticals a funded company?
Sompharmaceuticals is a funded company, having raised a total of $851.87K across 2 funding rounds to date. The company's 1st funding round was a Grant of $109.93K, raised on Oct 15, 2013.
What does Sompharmaceuticals do?
SomPharmaceuticals was founded in 2012 as a biopharmaceutical entity in Epalinges, Switzerland. Focus is placed on somatostatin analogue peptide medicines targeting rare neuroendocrine conditions, including orphan drug candidates for acromegaly and Cushings disease. Operations emphasize development for patient needs in these areas. As of May 13, 2016, the company has been operated as a subsidiary of Amryt Pharma.
Who are the top competitors of Sompharmaceuticals?
Sompharmaceuticals's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Who are Sompharmaceuticals's investors?
Sompharmaceuticals has 1 investor. Key investors include Amryt Pharma.